Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pancreatic enzyme replacement therapy use in acute pancreatitis - a systematic review of current practice.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026
Same author

Reimagining the Synthetic Biology DBTL Cycle with Machine Learning.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Mature tertiary lymphoid structures in pilonidal sinus disease.

JID innovations : skin science from molecules to population health·2026
Same author

Predictive Biomarkers for Immune Checkpoint Inhibitor Efficacy: Challenges, Innovations, and a Pathway to Precision Medicine in the Era of Cancer Immunotherapy.

Clinical chemistry·2026
Same author

Non-small Cell Lung Cancer in Metastatic Renal Cell Carcinoma Patients.

Clinical genitourinary cancer·2026
Same author

How power is conceptualized and operationalized in evidence-based intervention implementation: a scoping review.

Implementation science : IS·2026

Related Experiment Video

Updated: Jun 18, 2026

Robot-assisted Partial Splenectomy
08:34

Robot-assisted Partial Splenectomy

Published on: January 2, 2026

Benign symmetric lipomatosis

Steuart Rorke, Matthew Lee, Vachara Niumsawatt

    Pathology
    |November 11, 2009
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata
    07:58

    Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata

    Published on: November 23, 2017

    Related Experiment Videos

    Last Updated: Jun 18, 2026

    Robot-assisted Partial Splenectomy
    08:34

    Robot-assisted Partial Splenectomy

    Published on: January 2, 2026

    Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata
    07:58

    Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata

    Published on: November 23, 2017